19
Views
1
CrossRef citations to date
0
Altmetric
Current Opinion

Selective bloodletting for severe ulcerative colitis

, &
Pages 416-417 | Received 26 Sep 2003, Accepted 18 Dec 2003, Published online: 08 Jul 2009

References

  • Allison MC, Dhillon AP, Lewis WG, Pounder RE, editors. Inflammatory Bowel Disease. London: Mosby; 1998.
  • van Dullemen HM, van Deventer SJ, Hommes DW, Bijil HA, Woody J. Treatment of Crohn’s disease with anti-tumour necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129–35.
  • Stack WA, Long RG, Hawkey CJ. Short and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis. Aliment Pharmacol Ther 1998;12:973–8.
  • Hanai H, Watanabe F, Takeuchi K, Iida T, Yamada M, Iwaoka Y, et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled study. Clin Gastroenterol Hepatol 2003;1:28–35.
  • Shimoyama T, Sawada K, Hiwatashi N, Sawada T, Matsueda K, Munakata A, et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis 2001;16:1–9.
  • Hanai H, Watanabe F, Saniabadi AR, Matsushitai I, Takeuchi K, Iida T. Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis. Dig Dis Sci 2002;47:2349–53.
  • Sawada K, Muto T, Shimoyama T, Satomi M, Sawada T, Nagawa H, et al. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Dis 2003;9:307–32.
  • Tomomasa T, Kobayashi A, Kaneko H, Mika S, Maisawa S, Chino Y, et al. Granulocyte adsorptive apheresis for pediatric patients with ulcerative colitis. Dig Dis Sci 2003;48:750–4.
  • Kohgo Y, Hibi H, Chiba T, Shimoyama T, Muto T, Yamamura K, et al. Study group for alternative therapies in ulcerative colitis patients. Leukocyte apheresis using a centrifugal cell separator in refractory ulcerative colitis: a multicenter open label trial. Ther Apher 2002;6:255–60.
  • Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002;123:450–60.
  • Ohara M, Saniabadi AR, Hirata I, Adachi M, Agishi T, et al. Granulocyte apheresis in the treatment of patients with rheumatoid arthritis. Artif Organs 1997;21:989–94.
  • Truelove SC, Witts LJ. Cortisone in the treatment of ulcerative colitis: final report on a therapeutic trial. Br Med J 1955;2: 1041–8.
  • Saniabadi AR, Hanai H, Takeuchi K, Umemura K, Nakashima M, Adachi T, et al. Adacolumn, an adsorptive carrier-based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 2003;7:48–59.
  • Matsui T, Nishimura T, Matake H, Ohta T, Sakurai T, Yao T. Granulocytapheresis for Crohn’s disease: a report on seven refractory patients. Am J Gastroenterol 2003;98:511–2.
  • Ortolano GA, Capetandes A, Wenz B. A review ofleukofiltration therapy for decreasing the morbidity associated with cardiopulmonary bypass and acute inflammatory bowel disease. Ther Apher 2002;6:119–29.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.